Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Rahmouni is active.

Publication


Featured researches published by A. Rahmouni.


international conference on functional imaging and modeling of heart | 2011

Trials on tissue contractility estimation from cardiac cine MRI using a biomechanical heart model

Radomir Chabiniok; Philippe Moireau; Pierre-François Lesault; A. Rahmouni; Jean-François Deux; Dominique Chapelle

In this paper we apply specific data assimilation methods in order to estimate regional contractility parameters in a biomechanical heart model, using as measurements real Cine MR images obtained in an animal experiment. We assess the effectiveness of this estimation based on independent knowledge of the controlled infarcted condition, and on late enhancement images. Moreover, we show that the estimated contractility values can improve the model behavior in itself, and that they can serve as an indicator of the local heart function, namely, to assist medical diagnosis for the post-infarct detection of hypokinetic or akinetic regions in the myocardial tissue.


Journal of Vascular and Interventional Radiology | 2013

Image Guidance for Endovascular Repair of Complex Aortic Aneurysms: Comparison of Two-dimensional and Three-dimensional Angiography and Image Fusion

Vania Tacher; M. Lin; Pascal Desgranges; Jean Francois Deux; Thijs Grünhagen; Jean Pierre Becquemin; Alain Luciani; A. Rahmouni; Hicham Kobeiter

PURPOSE To evaluate the feasibility of image fusion (IF) of preprocedural arterial-phase computed tomography with intraprocedural fluoroscopy for roadmapping in endovascular repair of complex aortic aneurysms, and to compare this approach versus current roadmapping methods (ie, two-dimensional [2D] and three-dimensional [3D] angiography). MATERIALS AND METHODS Thirty-seven consecutive patients with complex aortic aneurysms treated with endovascular techniques were retrospectively reviewed; these included aneurysms of digestive and/or renal arteries and pararenal and juxtarenal aortic aneurysms. All interventions were performed with the same angiographic system. According to the availability of different roadmapping software, patients were successively placed into three intraprocedural image guidance groups: (i) 2D angiography (n = 9), (ii) 3D rotational angiography (n = 14), and (iii) IF (n = 14). X-ray exposure (dose-area product [DAP]), injected contrast medium volume, and procedure time were recorded. RESULTS Patient characteristics were similar among groups, with no statistically significant differences (P ≥ .05). There was no statistical difference in endograft deployment success between groups (2D angiography, eight of nine patients [89%]; 3D angiography and IF, 14 of 14 patients each [100%]). The IF group showed significant reduction (P < .0001) in injected contrast medium volume versus other groups (2D, 235 mL ± 145; 3D, 225 mL ± 119; IF, 65 mL ± 28). Mean DAP values showed no significant difference between groups (2D, 1,188 Gy · cm(2) ± 1,067; 3D, 984 Gy · cm(2) ± 581; IF, 655 Gy · cm(2) ± 457; P = .18); nor did procedure times (2D, 233 min ± 123; 3D, 181 min ± 53; IF, 189 min ± 60; P = .59). CONCLUSIONS The use of IF-based roadmapping is a feasible technique for endovascular complex aneurysm repair associated with significant reduction of injected contrast agent volume and similar x-ray exposure and procedure time.


European Radiology | 1999

Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging

C. M. Coffin; T. Diche; A.-E. Mahfouz; M. Alexandre; F. Caseiro-Alves; A. Rahmouni; N. Vasile; Didier Mathieu

Abstract. The aim of this work was to study the ability of mangafodipir trisodium (Mn-DPDP)-enhanced MR imaging in differentiating malignant from benign hepatocellular tumors. Eleven patients with pathologically proved hepatocellular carcinomas, six with focal nodular hyperplasias, and one with a single hepatocellular adenoma were examined by spin-echo and gradient-echo T1-weighted sequences before, 1 h after, and 24 h after intravenous injection of Mn-DPDP (5 μmol/kg). Quantitative analysis including enhancement and lesion-to-liver contrast-to-noise ratio, and qualitative analysis including the presence of a central area and a capsule were done on pre- and post-Mn-DPDP-enhanced images. Enhancement was observed in all the tumors with significant improvement (p < 0.05) in contrast-to-noise ratio 1 h after, and 24 h after intravenous injection of Mn-DPDP. There were no significant differences in the mean enhancement and the mean contrast-to-noise ratio (CNR) between benign and malignant tumors. No enhancement was seen within internal areas observed in 7 hepatocellular carcinomas, and in 5 focal nodular hyperplasias, and within capsules which were observed in 9 hepatocellular carcinomas. In our study, Mn-DPDP increased CNR of both benign and malignant tumors but did not enable differentiation between benign and malignant tumors of hepatocellular nature.


Biomechanics and Modeling in Mechanobiology | 2012

Estimation of tissue contractility from cardiac cine-MRI using a biomechanical heart model

Radomir Chabiniok; Philippe Moireau; Pierre-François Lesault; A. Rahmouni; Jean-François Deux; Dominique Chapelle

The objective of this paper is to propose and assess an estimation procedure—based on data assimilation principles—well suited to obtain some regional values of key biophysical parameters in a beating heart model, using actual Cine-MR images. The motivation is twofold: (1) to provide an automatic tool for personalizing the characteristics of a cardiac model in order to achieve predictivity in patient-specific modeling and (2) to obtain some useful information for diagnosis purposes in the estimated quantities themselves. In order to assess the global methodology, we specifically devised an animal experiment in which a controlled infarct was produced and data acquired before and after infarction, with an estimation of regional tissue contractility—a key parameter directly affected by the pathology—performed for every measured stage. After performing a preliminary assessment of our proposed methodology using synthetic data, we then demonstrate a full-scale application by first estimating contractility values associated with 6 regions based on the AHA subdivision, before running a more detailed estimation using the actual AHA segments. The estimation results are assessed by comparison with the medical knowledge of the specific infarct, and with late enhancement MR images. We discuss their accuracy at the various subdivision levels, in the light of the inherent modeling limitations and of the intrinsic information contents featured in the data.


Abdominal Imaging | 1992

Value of CT and sonography in the conservative management of acute splenoportal and superior mesenteric venous thrombosis

A. Rahmouni; Didier Mathieu; Mondher Golli; Philippe Douek; Marie Christine Anglade; Hubert Caillet; Norbert Vasile

Acute splenoportal and superior mesenteric venous thrombosis were diagnosed on sonography and computed tomography (CT) in six patients. Sonography demonstrated the presence of echoic material filling the involved vessels in all patients. Precontrast CT scans demonstrated an increased, intra luminal density of the clots in four patients with splenoportal thrombosis. However, in two cases of superior mesenteric venous thrombosis, no hyperdensity was observed within the lumens. Nevertheless, the clots were always visualized as low-density regions in the vessel lumens after bolus injection. Intravenous anticoagulant therapy was started immediately after the diagnosis. All patients were evaluated twice a week with sonography and/or CT until recanalization occurred. The patency of the previously involved vessels was assessed from 6 days to 4 weeks after the acute episode (average time of recanalization: 17 days) without development of collateral pathways. It is concluded that, in the absence of clinical signs of a life-threatening process, a conservative management of acute splanchnic thrombosis can be successfully achieved by (1) early diagnosis, (2) efficacious intravenous anticoagulant therapy, (3) careful imaging follow-up of these patients by sonography and/or CT during the acute phase and, finally, (4) by an extensive search for a hypercoagulable state.


Abdominal Imaging | 1997

Hyperintense benign liver lesions on spin-echo T1-weighted MR images: pathologic correlations

Didier Mathieu; M. Paret; A.-E. Mahfouz; F. Caseiro-Alves; J. Tran Van Nhieu; Marie-Christine Anglade; A. Rahmouni; Norbert Vasile

Abstract.Background: To determine the incidence of hyperintensity on T1-weighted spin echo (SE) images in benign liver lesions, value of fat-suppressed magnetic resonance (MR) imaging for the detection of fat within these lesions, and the causes of hyperintensity by correlation to pathologic examinations. Methods: Five hundred forty-nine patients with 805 benign liver lesions including 585 hemangiomas, 188 focal nodular hyperplasias (FNHs), 14 hepatic adenomas (HAs), 14 focal fatty infiltrations (FFIs), two biliary cystadenomas, and two hemorrhagic cysts were examined by T2-weighted and T1-weighted SE MR imaging. For hyperintense lesions on T1-weighted SE images, fat-suppressed images were obtained by selective presaturation of fat. Results: Thirty-two lesions (four FNHs, 10 HAs, 14 FFIs, two biliary cystadenomas, and two hemorrhagic cysts) appeared hyperintense on T1-weighted SE images; 21 of these became hypointense on the fat-suppressed T1 weighted SE images (one FNH, six HAs, and 14 FFIs) and contained fat at pathological examination. The other 11 lesions remained hyperintense on fat-suppressed T1-weighted SE images and had no fat deposition. Causes of hyperintensity in these cases were sinusoidal dilatation, copper deposition, hemorrhage, and high protein content. Conclusion: Among benign liver lesions, hyperintensity on T1-weighted SE images is rare (3.9%). Causes of this hyperintensity are fat deposition, copper accumulation, sinusoidal dilatation, hemorrhage, and high protein content. Fat-suppressed imaging can distinguish fat deposition from other causes of hyperintensity.


Journal of Magnetic Resonance Imaging | 2014

Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: Are we only looking at tumor necrosis?

Mélanie Chiaradia; Laurence Baranes; Jeanne Tran Van Nhieu; Alexandre Vignaud; Alexis Laurent; Thomas Decaens; Anaïs Charles-Nelson; Pierre Brugières; Sandrine Katsahian; M. Djabbari; Jean-François Deux; Iradj Sobhani; Mehdi Karoui; A. Rahmouni; Alain Luciani

To determine if intra‐voxel incoherent motion diffusion‐weighted imaging (IVIM‐DWI) parameters, including free molecular‐based (D) and perfusion‐related (D*, f) diffusion parameters, correlate with the degree of tumor necrosis and viable tumor in colo‐rectal cancer (CRC) metastasis.


Cancer Imaging | 2012

Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma.

Chieh Lin; Alain Luciani; Emmanuel Itti; Corinne Haioun; Safar; M. Meignan; A. Rahmouni

Abstract The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance imaging (diffusion MRI) in the assessment of lymphoma is reviewed. Diffusion MRI combining both anatomical and bio-physiological information is currently under investigation as a valuable tool in the oncology field including lymphoma, not only for staging but also for the assessment of response. Representative images for each purpose are shown. Diffusion MRI requires no administration of contrast medium and does not use ionizing radiation, which could be particularly advantageous for repeat follow-up surveillance in lymphoma patients. Diffusion MRI may prove to be a useful biomarker in clinical decision making for patients with lymphoma. Large-scale prospective studies are warranted to further establish its complementary value to the current standard of care, [18F]fluorodeoxyglucose positron emission tomography/computed tomography.


Cancer Imaging | 2010

Whole-body diffusion-weighted imaging in lymphoma.

Chieh Lin; Emmanuel Itti; Alain Luciani; Corinne Haioun; M. Meignan; A. Rahmouni

Abstract The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance imaging (DWI) in lymphoma is reviewed. DWI is capable of combining anatomical and functional information and is becoming a valuable tool in oncology, in particular for staging purposes. DWI may prove to be a useful biomarker in clinical decision making for patients with lymphoma. Large-scaled prospective studies are needed to confirm these preliminary results.


Journal of Magnetic Resonance Imaging | 1999

Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.

Didier Mathieu; Charles Coffin; Hicham Kobeiter; Filipe Caseiro-Alves; Ahmed Mahfouz; A. Rahmouni; Thierry Diche

With the use of available liver magnetic resonance contrast agents, such as mangafodipir (Mn‐DPDP), liver metastases do not exhibit enhancement on T1‐weighted images. This absence of enhancement is due to the lack of hepatocytes within these tumors. The purpose of this report is to demonstrate an unexpected enhancement on T1‐weighted images 30 minutes after injection of mangafodipir, in the case of endocrine liver metastases from a non‐hyperfunctioning neuroendocrine pancreatic tumor. Different hypotheses could explain this unexpected enhancement, such as increased arterial tumoral flow or high metabolic activity. Contrary to liver metastases of other origins, Mn‐DPDP enhancement can be present in neuroendocrine metastases. J. Magn. Reson. Imaging 1999;10:193–195.

Collaboration


Dive into the A. Rahmouni's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J.F. Deux

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Chieh Lin

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Vania Tacher

Johns Hopkins University

View shared research outputs
Researchain Logo
Decentralizing Knowledge